Literature DB >> 18761086

XIAP regulates bi-phasic NF-kappaB induction involving physical interaction and ubiquitination of MEKK2.

Gabriele Winsauer1, Ulrike Resch, Renate Hofer-Warbinek, Yvonne M Schichl, Rainer de Martin.   

Abstract

The transcription factor NF-kappaB is transiently activated by a wide variety of stress signals, including pro-inflammatory mediators, and regulates the expression of genes with e.g., immune, inflammatory, and anti-apoptotic functions. The strength and kinetics of its induction, as well as its ultimate down-regulation is subject to multiple levels of regulation. One such regulatory protein is X chromosome-linked inhibitor of apoptosis (XIAP) that, besides its anti-apoptotic properties, has been shown to enhance NF-kappaB activity, however, the underlying molecular mechanism has remained elusive. We show here that following TNFalpha stimulation XIAP regulates a second wave of NF-kappaB activation. XIAP interacts with and ubiquitinates MEKK2, a kinase that has previously been associated with bi-phasic NF-kappaB activation. We conclude that, through interaction with MEKK2, XIAP functions in an ubiquitin ligase dependent manner to evoke a second wave of NF-kappaB activation, resulting in the modulation of NF-kappaB target gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18761086     DOI: 10.1016/j.cellsig.2008.08.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  20 in total

Review 1.  Apoptotic cell signaling in cancer progression and therapy.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  Integr Biol (Camb)       Date:  2011-02-22       Impact factor: 2.192

2.  Nondegradative ubiquitination of apoptosis inducing factor (AIF) by X-linked inhibitor of apoptosis at a residue critical for AIF-mediated chromatin degradation.

Authors:  Eric M Lewis; Amanda S Wilkinson; Nicole Y Davis; David A Horita; John C Wilkinson
Journal:  Biochemistry       Date:  2011-12-02       Impact factor: 3.162

3.  Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice.

Authors:  Hridayesh Prakash; Marco Albrecht; Daniel Becker; Tanja Kuhlmann; Thomas Rudel
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

4.  Hepatitis B virus X protein promotes hepatoma cell proliferation via upregulation of MEKK2.

Authors:  Guang-yao Kong; Jun-ping Zhang; Shuai Zhang; Chang-liang Shan; Li-hong Ye; Xiao-dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2011-08-01       Impact factor: 6.150

5.  Regulation of the copper chaperone CCS by XIAP-mediated ubiquitination.

Authors:  Graham F Brady; Stefanie Galbán; Xuwen Liu; Venkatesha Basrur; Jonathan D Gitlin; Kojo S J Elenitoba-Johnson; Thomas E Wilson; Colin S Duckett
Journal:  Mol Cell Biol       Date:  2010-02-12       Impact factor: 4.272

Review 6.  XIAP as a ubiquitin ligase in cellular signaling.

Authors:  S Galbán; C S Duckett
Journal:  Cell Death Differ       Date:  2010-01       Impact factor: 15.828

7.  Control of inducible gene expression by signal-dependent transcriptional elongation.

Authors:  Diana C Hargreaves; Tiffany Horng; Ruslan Medzhitov
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

8.  Anthrax lethal toxin enhances IkappaB kinase activation and differentially regulates pro-inflammatory genes in human endothelium.

Authors:  Jason M Warfel; Felice D'Agnillo
Journal:  J Biol Chem       Date:  2009-07-20       Impact factor: 5.157

9.  Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1.

Authors:  Armelle-Natsuo Takeda; Tripat Kaur Oberoi-Khanuja; Gabor Glatz; Katharina Schulenburg; Rolf-Peter Scholz; Alejandro Carpy; Boris Macek; Attila Remenyi; Krishnaraj Rajalingam
Journal:  EMBO J       Date:  2014-06-28       Impact factor: 11.598

10.  Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer.

Authors:  Anindya Dey; Xunhao Xiong; Aleia Crim; Shailendra Kumar Dhar Dwivedi; Soumyajit Banerjee Mustafi; Priyabrata Mukherjee; Liangxian Cao; Nadiya Sydorenko; Ramil Baiazitov; Young-Choon Moon; Melissa Dumble; Thomas Davis; Resham Bhattacharya
Journal:  Mol Cancer Ther       Date:  2017-11-20       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.